FLGC 8-K Highlights Impairment, Volatility and Capital Risks

Rhea-AI Filing Summary

Flora Growth Corp. filed an 8-K reporting a material event and included standard forward-looking statements and risk disclosures. The filing lists potential risks that could materially affect results, including possible impairment charges if the market price of 0G declines below book value, share price volatility from future issuances, uncertainty from changing interest rates, the company’s ability to achieve and maintain profitability, regulatory and compliance complexities, potential changes in accounting for its 0G holdings, general economic conditions, growth management challenges, and access to capital. The statements are dated and the company disclaims any obligation to update forward-looking statements except as required by law.

Positive

• None.

Negative

• Impairment risk if market price of 0G falls below carrying value
• Share-price volatility from future issuances and convertible securities
• Interest-rate uncertainty that could affect financing costs and valuation
• Risk to profitability including inability to achieve or maintain profit
• Regulatory and compliance complexity that could increase costs or restrictions
• Potential accounting changes for 0G holdings that could alter reported results
• Access-to-capital risk including debt financing constraints

Insights

Corporate Reporting Analyst

TL;DR: The filing is largely forward-looking risk disclosure without new operational metrics.

The 8-K emphasizes a range of investor risks, notably potential impairment charges tied to declines in the market value of the company’s 0G holdings and share dilution/volatility from future issuances. These are standard disclosure items that highlight how market movements and financing decisions could affect reported equity and earnings.

The practical dependencies are observable market prices for 0G, financing activity, and regulatory developments; each could materialize quickly and affect near-term financials. Watch for subsequent filings that quantify any impairment, share issuances, or capital-raising actions within the next reporting period.

Risk & Compliance Specialist

TL;DR: The company flags regulatory, accounting, and capital-access risks that could constrain operations or reporting.

The disclosure draws attention to compliance complexity and possible changes in accounting treatment for the company’s 0G holdings, which could change reported results or require restatements if standards or interpretations shift. Access to capital and interest-rate volatility are also called out, highlighting financing risk.

Investors should monitor filings for regulatory outcomes, any announced accounting-policy changes, or debt/equity financings within 90 days to see if these risks are crystallizing into material financial effects.

false 2025-10-09 0001790169 00-0000000 Flora Growth Corp. 0001790169 2025-10-09 2025-10-09

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________________________

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): October 9, 2025

FLORA GROWTH CORP.
(Exact name of registrant as specified in its charter)

Ontario	001-40397	Not Applicable
(State or other jurisdiction	(Commission	(IRS Employer
of incorporation)	File Number)	Identification No.)

3230 W. Commercial Boulevard, Suite 180
Fort Lauderdale, Florida, United States 33132
(Address of principal executive offices) (ZIP Code)

Registrant’s telephone number, including area code: (954) 842-4989

Not Applicable
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbols		Name of each exchange on which registered
Common Shares, no par value		FLGC		NASDAQ Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b -2 of this chapter).

Emerging growth company ☑

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 7.01 Regulation FD Disclosure

On October 9, 2025, Flora Growth Corp., a corporation organized under the laws of the Province of Ontario (the "Company") published a blog post related to an update on the Company's financials and progress. A copy of that blog post is furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein in its entirety by reference. Such blog post, including any information that is incorporated herein, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise be subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the rules and regulations of the SEC thereunder, or the Exchange Act or the rules and regulations of the SEC thereunder, except as shall be expressly set forth by specific reference in such filing or document.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

99.1	Blog post of Flora Growth Corp. dated October 9, 2025
104	Cover Page Interactive Data File (embedded within the Inline XBRL document)

Cautionary Statement Regarding Forward-Looking Statements

This report contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as: "anticipate," "intend," "plan," "believe," "project," "estimate," "expect," strategy," "future," "likely," "may,", "should," "will" and similar references to future periods. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on the Company's current beliefs, expectations, and assumptions regarding the future of its business, future plans and strategies, projections, anticipated events and trends, the economy, and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks, and changes in circumstances that are difficult to predict and many of which are outside of the Company's control. The Company's actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following: (i) fluctuations in the market price of  $0G, the native cryptocurrency of the distributed AI infrastructure project 0G ("0G")  and any associated impairment charges that the Company may incur as a result of a decrease in the market price of 0G below the value at which the Company's 0G are carried on its balance sheet; (ii) volatility in our share price, including due to future issuances of common shares and securities convertible into common shares; (iii) the effect of and uncertainties related the ongoing volatility in interest rates; (iv) our ability to achieve and maintain profitability in the future; (v) the impact on our business of the regulatory environment and complexities with compliance related to such environment including changes in securities laws or other laws or regulations; (vi) changes in the accounting treatment relating to the Company's 0G holdings; (vii) our ability to respond to general economic conditions; (viii) our ability to manage our growth effectively and our expectations regarding the development and expansion of our business; (ix) our ability to access sources of capital, including debt financing and other sources of capital to finance operations and growth and (x) other risks and uncertainties more fully in the section captioned "Risk Factors" in the Company's most recent Annual Report on Form 10-K and other reports and/or registration statements we file with the SEC. As a result of these matters, changes in facts, assumptions not being realized, or other circumstances, the Company's actual results may differ materially from the expected results discussed in the forward-looking statements contained in this report. Forward-looking statements contained in this announcement are made as of this date, and the Company undertakes no duty to update such information except as required under applicable law.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	FLORA GROWTH CORP.
Date: October 10, 2025	By:	/s/ Dany Vaiman
	Name:	Dany Vaiman
	Title:	Chief Financial Officer

FAQ

What did Flora Growth (FLGC) disclose in the 8-K dated 2025-10-09?

Key disclosure: the company filed a material event notice containing forward-looking statements and a list of risks including potential impairment of 0G holdings, share volatility, interest-rate effects, regulatory and accounting risks, and access-to-capital concerns.

Does the filing report any realized impairment or quantified losses for FLGC?

No quantified impairment or specific loss figures are reported in the provided text.

What specific assets are mentioned as subject to impairment risk?

The filing refers to the company’s holdings of 0G and potential impairment charges if market price declines below carrying value.

Does the company commit to updating its forward-looking statements?

The company states it undertakes no duty to update forward-looking statements except as required by applicable law.

Which factors could cause the company’s actual results to differ materially?

Listed factors include market price declines, share issuances, interest-rate volatility, regulatory changes, accounting treatment changes, economic conditions, growth-management challenges, and access to capital.